The global Competent Cells Market is on a rapid growth trajectory, valued at US$ 2.1 billion in 2022. The market is projected to expand at an impressive CAGR of 11.1% during the forecast period, reaching a valuation of approximately US$ 5.9 billion by 2032.
Chemically competent cells dominated the market in 2021, accounting for about 67.8% of the market share. This product type continues to lead due to its high efficiency in DNA uptake and suitability for diverse genetic engineering applications, including cloning, protein expression, and transformation processes.
The growth of the competent cells market is driven by advancements in molecular biology, increased R&D investments in biotechnology, and the rising adoption of synthetic biology techniques. Additionally, the expanding demand for recombinant protein production and genetic studies is fueling market expansion globally.
A Full Report Analysis – https://www.futuremarketinsights.com/reports/competent-cells-market
Key Takeaways:
- Market Size: Valued at US$ 2.1 billion in 2022, projected to reach approximately US$ 5.9 billion by 2032.
- Growth Rate: Expected to grow at a robust CAGR of 11.1% during the forecast period.
- Leading Segment: Chemically competent cells held 67.8% market share in 2021, driven by their efficiency and wide application range.
- Market Drivers: Advancements in molecular biology, increasing use of genetic engineering, and growing demand for recombinant protein production.
Key Market Insights
- Current Market Size (2022): USD 2.1 billion
- Projected Market Size (2032): USD 5.9 billion
- CAGR (2022-2032): 11.1%
- Market Share of Chemically Competent Cells (2021): Approximately 67.8%
Growth Drivers
- Increasing Demand for Genetic Cloning: The rising need for molecular cloning and recombinant protein production is driving the demand for competent cells, which are essential for these processes.
- Advancements in Molecular Biology Techniques: Innovations and advancements in molecular cloning techniques are expanding the applications of competent cells, further fueling market growth.
- Investment in Biotechnology Research: Increased funding for life sciences research and biotechnology initiatives is contributing to the growth of the competent cells market.
- Rising Prevalence of Genetic Disorders: The growing incidence of genetic disorders is leading to higher demand for research and development in genetic engineering, which utilizes competent cells.
Regional Insights
- The North American market is expected to lead due to high levels of research activity and investment in biotechnology, with the USA accounting for a significant share.
- The Asia-Pacific region, particularly countries like China and India, is anticipated to witness rapid growth driven by advancements in biotechnology and increasing research activities.
Competitive Landscape
With several competitors in the competent cells market, the overall market is fragmented. To expand their customer base, leading companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
For instance:
- The VmaxTM X2 Competent Cells were introduced in January 2020 by SGI-DNA, the company behind the BioXpTM 3200 System and Gibson Assembly® Reagents. They are intended to produce two to four times as much soluble protein in half the time as current methods that rely on E. coli.
- Bluebird Bio announced the introduction of ZYNTEGLOTM Gene Therapy for Patients with Transfusion-Dependent -Thalassemia Who Do Not Have β?/β0 Genotype in Germany in January 2020.
Key Companies Profiled
- Agilent Technologies Inc.
- Genescript Biotech Corporation
- Bio-Rad Laboratories Inc
- Merck & Co Inc
- OriGene Technologies, Inc
- New England Biolabs Inc
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.,
- QIAGEN N.V.,
- Zymo Research Corporation
- Promega Corporation
- HiMedia Laboratories
- Avantor, Inc.
- Scarab Genomics, LLC
- Lucigen
- bluebird bio, Inc.
- Tonbo Biosciences
- TransGen Biotech
- Codex DNA, Inc.
Key Market Segments Covered in Competent Cells Industry Research
By Product:
- Chemically Competent Cells
- Electrocompetent Cells
By Application:
- Cloning
- Protein Expression
- Other Applications
By End User:
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
